National Health Investors Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de National Health Investors de 3.7% y 14.3% por año respectivamente. Se prevé que el BPA disminuya en un 1.2% al año. Se espera que la rentabilidad financiera sea de 9.6% en 3 años.

Información clave

4.6%

Tasa de crecimiento de los beneficios

0.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Health Care REITs	30.4%
Tasa de crecimiento de los ingresos	12.1%
Rentabilidad financiera futura	9.5%
Cobertura de analistas	Low
Última actualización	30 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

National Health Investors Q2 Earnings Preview

Aug 07

National Health Investors: A 5.8% Yield, And Little Else

Jun 29

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Apr 14

National Health Investors: Why This 7% Yielder Is A Buy On The Drop

Feb 06

National Health Management Believes The 6.4% Yield Is Sustainable

Nov 17

National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment

Oct 11

National Health Investors: Buy 'Em When They're Cheap

Sep 26

National Health Investors: The Most Bearish Bull Thesis I Hope To Ever Write

Aug 31

National Health: Not Out Of The Woods Yet

Aug 10

National Health Investors reaches deferral agreement with Bickford

Jun 17

Previsiones de crecimiento de beneficios e ingresos

NYSE:NHI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	387	136	N/A	N/A	3
12/31/2025	343	133	N/A	N/A	5
12/31/2024	320	125	N/A	N/A	4
3/31/2024	320	132	191	194	N/A
12/31/2023	320	136	181	184	N/A
9/30/2023	311	105	176	178	N/A
6/30/2023	307	110	171	171	N/A
3/31/2023	290	92	177	178	N/A
12/31/2022	279	66	185	185	N/A
9/30/2022	278	71	192	192	N/A
6/30/2022	275	68	198	198	N/A
3/31/2022	289	85	193	193	N/A
12/31/2021	297	112	211	211	N/A
9/30/2021	307	142	213	213	N/A
6/30/2021	317	154	224	224	N/A
3/31/2021	327	159	232	232	N/A
12/31/2020	330	185	232	232	N/A
9/30/2020	332	190	233	233	N/A
6/30/2020	330	190	231	231	N/A
3/31/2020	325	186	224	224	N/A
12/31/2019	318	160	241	241	N/A
9/30/2019	310	155	236	236	N/A
6/30/2019	303	154	233	233	N/A
3/31/2019	298	152	233	233	N/A
12/31/2018	295	154	208	208	N/A
9/30/2018	292	155	208	208	N/A
6/30/2018	288	153	205	205	N/A
3/31/2018	285	154	198	198	N/A
12/31/2017	279	159	N/A	198	N/A
9/30/2017	273	163	N/A	194	N/A
6/30/2017	264	157	N/A	189	N/A
3/31/2017	255	163	N/A	185	N/A
12/31/2016	247	152	N/A	177	N/A
9/30/2016	240	165	N/A	173	N/A
6/30/2016	235	165	N/A	168	N/A
3/31/2016	230	152	N/A	167	N/A
12/31/2015	227	149	N/A	164	N/A
9/30/2015	215	122	N/A	154	N/A
6/30/2015	201	114	N/A	145	N/A
3/31/2015	190	108	N/A	136	N/A
12/31/2014	177	102	N/A	126	N/A
9/30/2014	165	98	N/A	123	N/A
6/30/2014	151	95	N/A	118	N/A
3/31/2014	134	88	N/A	109	N/A
12/31/2013	118	78	N/A	104	N/A
9/30/2013	108	81	N/A	97	N/A
6/30/2013	102	72	N/A	92	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (3.7% al año) de NHI es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (3.7% al año) de NHI crezcan menos que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de NHI crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (14.3% al año) de NHI crezcan más rápidamente que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 14.3% al año) de NHI crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de NHI sea baja dentro de 3 años (9.6%).

National Health Investors Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.2% to US$62.00

Price target increased by 7.5% to US$59.86

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Consensus EPS estimates fall by 21%

Price target increased to US$62.71

Recent updates

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

Consensus EPS estimates fall by 21%

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Chief Investment Officer exercised options and sold US$220k worth of stock

Price target increased to US$62.71

Independent Director recently bought US$99k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

National Health Investors Q2 Earnings Preview

National Health Investors, Inc. to Report Q2, 2022 Results on Aug 08, 2022

National Health Investors: A 5.8% Yield, And Little Else

Upcoming dividend of US$0.90 per share

Consensus forecasts updated

National Health Investors, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

An unknown buyer acquired Two Assisted Living Facilities Located in Texas from National Health Investors, Inc. (NYSE:NHI) for $7.8 million.

National Health Investors, Inc. to Report Q1, 2022 Results on May 09, 2022

National Health Investors, Inc. (NYSE:NHI) announces an Equity Buyback for $240 million worth of its shares.

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Discovery Senior Living and National Health Investors, Inc. (NYSE:NHI) acquired 9-Community Independent Living Portfolio from Holiday AL Management Sub LLC.

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Declares First Quarter Dividend, Payable on May 6

An unknown buyer acquired Medical Office Building Located in Texas fromNational Health Investors, Inc. (NYSE:NHI) for approximately $5.1 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors: Why This 7% Yielder Is A Buy On The Drop